ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma

Cancer Letters
Naoya MiyashitaAkira Saito

Abstract

The master regulator of neuroendocrine differentiation, achaete-scute complex homolog 1 (ASCL1) defines a subgroup of lung adenocarcinoma. However, the mechanistic role of ASCL1 in lung tumorigenesis and its relation to the immune microenvironment is principally unknown. Here, the immune landscape of ASCL1-positive lung adenocarcinomas was characterized by immunohistochemistry. Furthermore, ASCL1 was transduced in mouse lung adenocarcinoma cell lines and comparative RNA-sequencing and secretome analyses were performed. The effects of ASCL1 on tumorigenesis were explored in an orthotopic syngeneic transplantation model. ASCL1-positive lung adenocarcinomas revealed lower infiltration of CD8+, CD4+, CD20+, and FOXP3+ lymphocytes and CD163+ macrophages indicating an immune desert phenotype. Ectopic ASCL1 upregulated cyclin transcript levels, stimulated cell proliferation, and enhanced tumor growth in mice. ASCL1 suppressed secretion of chemokines, including CCL20, CXCL2, CXCL10, and CXCL16, indicating effects on immune cell trafficking. In accordance with lower lymphocytes infiltration, ASCL1-positive lung adenocarcinomas demonstrated lower abundance of CXCR3-and CCR6-expressing cells. In conclusion, ASCL1 mediates its tumor-promot...Continue Reading

References

Dec 3, 2005·Cancer Research·Hirotaka OsadaTakashi Takahashi
Nov 3, 2009·Immunity·Natalia Martin-OrozcoChen Dong
Jan 22, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisDavid Yankelewitz
Sep 29, 2011·PloS One·Sophie KirshbergOri Wald
Jul 31, 2013·Immunity·Daniel S Chen, Ira Mellman
Sep 5, 2015·International Journal of Cancer. Journal International Du Cancer·Lydia MederReinhard Buettner
Oct 20, 2015·Cancer Letters·Haidong TangYang-Xin Fu
Feb 5, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Roy M BremnesTom Dønnem
Jul 2, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ting-Yuan David ChengMary E Reid
Aug 9, 2016·BMC Cancer·Johanna S M MattssonMaria A Svensson
Oct 5, 2016·JCI Insight·Dijana DjureinovicPatrick Micke
Jan 20, 2017·Nature·Daniel S Chen, Ira Mellman
Apr 28, 2017·Journal of Thoracic Disease·Artjoms Spaks
May 31, 2017·Nature Reviews. Immunology·Nisha NagarshethWeiping Zou
Oct 4, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Masafumi HorieTakahide Nagase
Apr 19, 2018·International Journal of Cancer. Journal International Du Cancer·Linnéa La FleurJohan Botling
Jun 7, 2018·Journal for Immunotherapy of Cancer·Tolga TuranJosue Samayoa
Aug 20, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Naoya MiyashitaTakahide Nagase
Oct 10, 2018·Cancer Discovery·Shunsuke KitajimaDavid A Barbie
Mar 31, 2019·Nature Reviews. Cancer·Charles M RudinAdi F Gazdar
Feb 19, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Carminia M Della CorteLauren A Byers

❮ Previous
Next ❯

Citations

May 14, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Olga BogatyrovaPatrick Micke
Jan 9, 2022·Journal of Cancer Research and Clinical Oncology·Yamei ChenMing Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

CD4/CD8 Signaling

Cluster of differentiation 4 and 8 (CD8 and CD8) are glycoproteins founds on the surface of immune cells. Here is the latest research on their role in cell signaling pathways.